The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9062045, 12 ID: ALA3703949
Chembl Id: CHEMBL3703949
PubChem CID: 71534666
Max Phase: Preclinical
Molecular Formula: C24H21N7OS
Molecular Weight: 455.55
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(-c2ccc3nnc(Sc4ccc5ncc(N6CC7(COC7)C6)cc5c4)n3c2)cn1
Standard InChI: InChI=1S/C24H21N7OS/c1-29-10-18(8-26-29)16-2-5-22-27-28-23(31(22)11-16)33-20-3-4-21-17(7-20)6-19(9-25-21)30-12-24(13-30)14-32-15-24/h2-11H,12-15H2,1H3
Standard InChI Key: GNCNEAGBGRHTAT-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 455.55Molecular Weight (Monoisotopic): 455.1528AlogP: 3.67#Rotatable Bonds: 4Polar Surface Area: 73.37Molecular Species: NEUTRALHBA: 9HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.42CX LogP: 2.47CX LogD: 2.47Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.41Np Likeness Score: -1.92
References 1. (2015) Triazolopyridine compounds, 2. Manevski N, King L, Pitt WR, Lecomte F, Toselli F.. (2019) Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery., 62 (24): [PMID:31385704 ] [10.1021/acs.jmedchem.9b00875 ]